Wikidata entity: Q62810737
Quantities
| P4135 | maximum age | 85 |
| P2899 | minimum age | 18 |
| P1132 | number of participants | 280 |
| P6099 | clinical trial phase | ... | Q42824440 (phase II clinical trial) | phase II clinical trial |
| P17 | country | ... | Q30 (United States) | United States |
| P17 | country | ... | Q31 (Belgium) | Belgium |
| P17 | country | ... | Q17 (Japan) | Japan |
| P17 | country | ... | Q36 (Poland) | Poland |
| P17 | country | ... | Q38 (Italy) | Italy |
| P582 | end time | ... | 2020-03-30 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P1050 | medical condition | ... | Q943897 (gastroparesis) | gastroparesis |
| P4844 | research intervention | ... | Q42038 (maleic acid) | maleic acid |
| P6153 | research site | ... | Q1130172 (Mayo Clinic) | Mayo Clinic |
| P6153 | research site | ... | Q4897536 (Beth Israel Deaconess Medical Center) | Beth Israel Deaconess Medical Center |
| P6153 | research site | ... | Q30254036 (Temple University Hospital) | Temple University Hospital |
| P6153 | research site | ... | Q30270033 (PMG Research) | PMG Research |
| P6153 | research site | ... | Q33526980 (University of Kansas Medical Center) | University of Kansas Medical Center |
| P6153 | research site | ... | Q50035610 (Precision Research Institute) | Precision Research Institute |
| P6153 | research site | ... | Q175241 (University of Antwerp) | University of Antwerp |
| P6153 | research site | ... | Q230492 (University of Michigan) | University of Michigan |
| P6153 | research site | ... | Q691851 (University of Naples Federico II) | University of Naples Federico II |
| P580 | start time | ... | 2018-10-17 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Twice-Daily Oral Administration of a Peripherally Acting Dopamine Receptor D2/D3 Antagonist, TAK-906 for the Treatment of Adult Subjects With Symptomatic Idiopathic or Diabetic Gastroparesis | ??? |
| P3098 | ClinicalTrials.gov ID | NCT03544229 |
Why not click here or view trends?
log id: 4880982